A research project by National Taiwan Normal University (NTNU), National Applied Research Laboratories and National Cheng Kung University (NCKU) might provide a critical first step to cures for polycystic kidney disease or similar conditions, researchers said.
The team said that the overexpression of exogenous neutrophil gelatinase-associated lipocalin (NGAL), a biomarker for acute and chronic renal injuries, had the potential to help reduce cystic progression and prolong the lifespan of people with such diseases.
NGAL is considered one of the most promising novel biomarkers to help doctors detect acute kidney injuries and chronic kidney diseases early enough to offer preventive measures, they said.
The team said that tests on mice showed that animals with kidney conditions that had an overexpression of exogenous kidney-specific NGAL also had reduced cystic progression and prolonged lifespans compared with mice with endogenous NGAL or NGAL deficiencies.
The biomarker is also associated with reductions in interstitial fibrosis and proliferation, and augmented apoptosis, the team said.
The project has been going for more than 13 years, NTNU said, adding that the team is filing for a multinational patent for its discoveries and is looking to begin clinical trials soon.
The results have also been reported by Kidney International, the official journal of the International Society of Nephrology.
NTNU said that autosomal dominant polycystic kidney disease is the most common inherited kidney disorder, affecting an estimated 12.5 million people globally, and that the condition does not have any effective treatment.
According to National Health Insurance Administration statistics, people with the condition comprised roughly 5 to 10 percent of all patients on dialysis, costing the nation roughly NT$3.4 billion (US$107 million) per year.
Alain Robert, known as the "French Spider-Man," praised Alex Honnold as exceptionally well-prepared after the US climber completed a free solo ascent of Taipei 101 yesterday. Robert said Honnold's ascent of the 508m-tall skyscraper in just more than one-and-a-half hours without using safety ropes or equipment was a remarkable achievement. "This is my life," he said in an interview conducted in French, adding that he liked the feeling of being "on the edge of danger." The 63-year-old Frenchman climbed Taipei 101 using ropes in December 2004, taking about four hours to reach the top. On a one-to-10 scale of difficulty, Robert said Taipei 101
Nipah virus infection is to be officially listed as a category 5 notifiable infectious disease in Taiwan in March, while clinical treatment guidelines are being formulated, the Centers for Disease Control (CDC) said yesterday. With Nipah infections being reported in other countries and considering its relatively high fatality rate, the centers on Jan. 16 announced that it would be listed as a notifiable infectious disease to bolster the nation’s systematic early warning system and increase public awareness, the CDC said. Bangladesh reported four fatal cases last year in separate districts, with three linked to raw date palm sap consumption, CDC Epidemic Intelligence
US climber Alex Honnold left Taiwan this morning a day after completing a free-solo ascent of Taipei 101, a feat that drew cheers from onlookers and gained widespread international attention. Honnold yesterday scaled the 101-story skyscraper without a rope or safety harness. The climb — the highest urban free-solo ascent ever attempted — took just more than 90 minutes and was streamed live on Netflix. It was covered by major international news outlets including CNN, the New York Times, the Guardian and the Wall Street Journal. As Honnold prepared to leave Taiwan today, he attracted a crowd when he and his wife, Sanni,
Taiwanese and US defense groups are collaborating to introduce deployable, semi-autonomous manufacturing systems for drones and components in a boost to the nation’s supply chain resilience. Taiwan’s G-Tech Optroelectronics Corp subsidiary GTOC and the US’ Aerkomm Inc on Friday announced an agreement with fellow US-based Firestorm Lab to adopt the latter’s xCell, a technology featuring 3D printers fitted in 6.1m container units. The systems enable aerial platforms and parts to be produced in high volumes from dispersed nodes capable of rapid redeployment, to minimize the risk of enemy strikes and to meet field requirements, they said. Firestorm chief technology officer Ian Muceus said
RSS